HomeAbout

TL;DR CNBC


Arthritis drug shows benefit for only the sickest of coronavirus patients, pushing drugmakers to narrow drug trial - TL;DR CNBC

Arthritis drug shows benefit for only the sickest of coronavirus patients, pushing drugmakers to narrow drug trial

Publishing timestamp: 2020-04-27 11:01:01


Summary


Sentiment: NEGATIVE

Tickers: REGNSAN-FR

Keywords:

Source: https://www.cnbc.com/2020/04/27/coronavirus-regeneron-sanofi-drug-shows-benefit-for-sickest-patients.html


Developed by Leo Phan